|
ARHGAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.08402217494586E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12070019930854E-10 |
| Normal-vs-Stage2 |
1.961870E-03 |
| Normal-vs-Stage3 |
2.02159999962426E-07 |
| Normal-vs-Stage4 |
4.212800E-01 |
| Stage1-vs-Stage2 |
3.603400E-01 |
| Stage1-vs-Stage3 |
4.011600E-02 |
| Stage1-vs-Stage4 |
6.166000E-02 |
| Stage2-vs-Stage3 |
7.459200E-01 |
| Stage2-vs-Stage4 |
7.976300E-02 |
| Stage3-vs-Stage4 |
8.041200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93478566501426E-12 |
| Normal-vs-AfricanAmerican |
9.34579999944951E-07 |
| Normal-vs-Asian |
3.576600E-01 |
| Caucasian-vs-AfricanAmerican |
9.707400E-01 |
| Caucasian-vs-Asian |
4.589000E-01 |
| AfricanAmerican-vs-Asian |
5.852000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.00590671745249E-12 |
| Normal-vs-Female |
2.36980435275314E-11 |
| Male-vs-Female |
3.664000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.71209999999733E-05 |
| Normal-vs-Extreme_Weight |
1.78810000139862E-09 |
| Normal-vs-Obese |
4.60850002603763E-09 |
| Normal-vs-Extreme_Obese |
3.361500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.388600E-01 |
| Normal_Weight-vs-Obese |
9.995800E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.440200E-01 |
| Extreme_Weight-vs-Obese |
6.072000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.959200E-01 |
| Obese-vs-Extreme_Obese |
4.546600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.016310E-03 |
| Normal-vs-Age(41-60Yrs) |
2.72626365926953E-12 |
| Normal-vs-Age(61-80Yrs) |
1.61350044436404E-10 |
| Normal-vs-Age(81-100Yrs) |
4.648900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.705600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.936200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.672600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.462400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.952400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.845000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.54209978120434E-13 |
| Normal-VS-Type2 PRCC |
1.64360000054486E-07 |
| Normal-VS-KIRP CIMP |
1.363540E-02 |
| Normal-VS-Unclassified PRCC |
3.35909999815698E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.805040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.326800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.876400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.734420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.238200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.949200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.18480000044619E-08 |
| Normal-vs-N1 |
3.323700E-03 |
| Normal-vs-N2 |
8.590300E-02 |
| N0-vs-N1 |
2.443400E-01 |
| N0-vs-N2 |
5.661400E-01 |
| N1-vs-N2 |
2.658800E-01 |
|
|
